CD&R Agrees to Buy UDG Healthcare for About $3.9 Billion (1)

Clayton, Dubilier & Rice agreed to buy UDG Healthcare Plc for a sweetened offer of about 2.8 billion pounds ($3.9 billion) in cash after winning the backing of key shareholders.

The price amounts to 1,080 pence a share, the companies said in a statement Tuesday. Last week, CD&R said it was considering raising its offer to that level after some of Dublin-based UDG’s largest investors complained that a previous bid was too low.

The pace of health-care acquisitions has accelerated during the pandemic, and UDG, which provides a range of services to pharmaceutical customers in about 25 countries, said last ...